Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mary-Katherine Monahan is active.

Publication


Featured researches published by Mary-Katherine Monahan.


Archive | 2001

Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors

Bernd Riedl; Jacques Dumas; Uday Khire; Timothy B. Lowinger; William J. Scott; Roger A. Smith; Jill E. Wood; Mary-Katherine Monahan; Reina Natero; Joel Renick; Robert Sibley


Archive | 2000

.omega.-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors

Bernd Riedl; Jacques Dumas; Uday Khire; Timothy B. Lowinger; William J. Scott; Roger A. Smith; Jill E. Wood; Mary-Katherine Monahan; Reina Natero; Joel Renick; Robert Sibley


Organic Process Research & Development | 2002

A Scaleable Synthesis of BAY 43-9006: A Potent Raf Kinase Inhibitor for the Treatment of Cancer

Donald Bankston; Jacques Dumas; Reina Natero; Bernd Riedl; Mary-Katherine Monahan; Robert Sibley


Archive | 2002

Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas

Jacques Dumas; Bernd Riedl; Uday Khire; Robert Sibley; Holia Hatoum-Mokdad; Mary-Katherine Monahan; David E. Gunn; Timotthy B. Lowinger; William J. Scott; Roger A. Smith; Jill E. Wood


Bioorganic & Medicinal Chemistry Letters | 2004

Omega-carboxypyridyl substituted ureas as Raf kinase inhibitors: SAR of the amide substituent.

Uday Khire; Donald Bankston; James Barbosa; David R. Brittelli; Yolanda V Caringal; Robert O. Carlson; Jacques Dumas; Todd Gane; Sarah Heald; Barbara Hibner; Jeffrey S Johnson; Michael E. Katz; Nancy Kennure; Jill Kingery-Wood; Wendy Lee; Xiao-Gao Liu; Timothy B. Lowinger; Ian McAlexander; Mary-Katherine Monahan; Reina Natero; Joel Renick; Bernd Riedl; Hong Rong; Robert Sibley; Roger A. Smith; Donald John Wolanin


Archive | 2002

Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors

Jacques Dumas; Bernd Riedl; Uday Khire; Robert Sibley; Holia Hatoum-Mokdad; Mary-Katherine Monahan; David E. Gunn; Timotthy B. Lowinger; William J. Scott; Roger A. Smith; Jill E. Wood


Archive | 2001

Omega-carboxyaryl subsituted diphenyl ureas as raf kinase inhibitors

Bernd Riedl; Jacques Dumas; Uday Khire; Timothy B. Lowinger; William J. Scott; Roger A. Smith; Jill E. Wood; Mary-Katherine Monahan; Reina Natero; Joel Renick; Robert Sibley


Archive | 2000

W-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors

Bernd Riedl; Jacques Dumas; Uday Khire; Timothy B. Lowinger; William J. Scott; Roger A. Smith; Jill E. Wood; Mary-Katherine Monahan; Reina Natero; Joel Renick; Robert Sibley


Archive | 2001

Omega-carboxyaryl substituted disphenyl ureas as raf kinase inhibitors

Bernd Riedl; Jaques Dumas; Uday Khire; Timothy B. Lowinger; William J. Scott; Roger A. Smith; Jill E. Wood; Mary-Katherine Monahan; Reina Natero; Joel Renick; Robert Sibley


Archive | 2001

omega-carboxyyaryl substituted diphenyl ureas as raf kinase inhibitors

Bernd Riedl; Jacques Dumas; Uday Khire; Timothy B. Lowinger; William J. Scott; Roger A. Smith; Jill E. Wood; Mary-Katherine Monahan; Reina Natero; Joel Renick; Robert Sibley

Collaboration


Dive into the Mary-Katherine Monahan's collaboration.

Researchain Logo
Decentralizing Knowledge